Pharmaceutical research, driving advancements in drug development and treatment modalities, is intertwined with complex ethical considerations. In clinical trials, ethical frameworks emphasize the principles of informed consent, ensuring the welfare and rights of research participants, and maintaining scientific integrity. Before testing on humans, potential drugs undergo rigorous testing in laboratory settings (in vitro) and animal models (in vivo) to evaluate their safety, efficacy, and potential side effects. Researchers work on developing the most effective and safe form of the drug, considering factors like dosage form, route of administration, and stability. Discussions around equitable access to experimental treatments, especially in global clinical trials, underscore ethical imperatives related to justice and fairness. Addressing potential conflicts of interest, transparent reporting of research findings, and safeguarding the rights of vulnerable populations are integral to ethical practices in pharmaceutical research. As the landscape of drug discovery evolves, ethical discourse remains central to balancing the pursuit of scientific innovation with the ethical responsibilities to research participants and the broader community.
Title : Overview of artificial intelligence in healthcare
Adele Webb, Strategic Education, Inc., United States
Title : Will be Updated Soon....
Ismat Mikky, Bloomfield College of Montclair State University, United States
Title : Beyond cultural competence: Integrating cultural intelligence into professional nursing education and practice
Debra A Hrelic, University of North Carolina Wilmington, United States
Title : Artificial Intelligence (AI) and its impact on nursing: Challenges and opportunities
David John Wortley, International Society of Digital Medicine, United Kingdom
Title : Medication non adherence in community dwelling adults
Barbara M De Groot, Heartwell Services, United States
Title : Leading through the unknown: Keeping nursing teams motivated during times of uncertainty and change
Robin Adams Geiger, Ingenovis Health, United States